Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Increased immune activation in people living with HIV on antiretroviral therapy but not when compared with persons on HIV preexposure prophylaxis.
Infectious diseases (London, England)·2025
Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses.
Brain, behavior, and immunity·2024
Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences.
The Journal of infectious diseases·2024
IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosis.
Clinical chemistry and laboratory medicine·2024
COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
The Journal of infectious diseases·2023
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection.
Open forum infectious diseases·2023
Neuroprotective Effect of Imeglimin Hydrochloride on H2O2-Induced SH-SY5Y Cells.
Central nervous system agents in medicinal chemistry·2026